Cargando…

Preradioactive Iodine Thyroglobulin Levels as Predictors of Metastasis in Well-Differentiated Thyroid Carcinoma Patients

Objective The aim of this study was to determine the cut-off value of thyroglobulin (Tg) levels as a predictor of metastases in post total thyroidectomy patients with well-differentiated thyroid carcinoma (DTC). Materials and Methods A retrospective case-control study with an observational diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Darmawan, Budi, Sari, Meutia, Susilo, Stefani, Kartamihardja, Achmad Hussein S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665994/ https://www.ncbi.nlm.nih.gov/pubmed/36398311 http://dx.doi.org/10.1055/s-0042-1750396

Ejemplares similares

The effect of retinoic acid in the ability of cold solid thyroid nodule to take up radioactive iodine: A preliminary study
por: Lim, Andreas, et al.
Publicado: (2019)

Automated Bone Scan Index as Predictors of Survival in Prostate Cancer
por: Wiyanto, Joko, et al.
Publicado: (2017)

Metabolic Activity Value in the Posterior Cingulate Cortex Using F-18 Fluorodeoxyglucose Positron Emission Tomography Brain to Predict the Severity of Alzheimer's
por: Huda, Aulia, et al.
Publicado: (2017)

Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis
por: Wang, Chen, et al.
Publicado: (2017)

Antithyroglobulin Antibody as a Marker of Successful Ablation Therapy in Differentiated Thyroid Cancer
por: Dewi, Ayu Rosemeilia, et al.
Publicado: (2017)

Thyroglobulin Value Predict Iodine-123 Imaging Result in Differentiated Thyroid Cancer Patients
por: Campennì, Alfredo, et al.
Publicado: (2023)

Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience
por: Werner, R. A., et al.
Publicado: (2016)

The structure of natively iodinated bovine thyroglobulin
por: Kim, Kookjoo, et al.
Publicado: (2021)

The Role of Pre-ablative Stimulated Thyroglobulin and Thyroglobulin/ Thyroid-Stimulating Hormone Ratio for Predicting Metastasis in Thyroid Cancer
por: Demir, Fadime, et al.
Publicado: (2019)

Can Ultrasound Predict Malignancy in Patient with Thyroid Cold Nodule?
por: Wiyanto, Joko, et al.
Publicado: (2016)

Comparing the efficacy of thyroglobulin and thyroglobulin/ thyroid-stimulating hormone ratio models in predicting a successful response to radioactive iodine therapy
por: Ju, Yanli, et al.
Publicado: (2023)

The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis
por: Lin, Jen-Der, et al.
Publicado: (2018)

Utility of Stimulated Thyroglobulin in the Differentiate Thyroid Cancer
por: Romero, Fabiola, et al.
Publicado: (2021)

Preoperative serum thyroglobulin predicts initial distant metastasis in patients with differentiated thyroid cancer
por: Kim, Hosu, et al.
Publicado: (2017)

Can preoperative thyroglobulin antibody levels be used as a marker for well differentiated thyroid cancer?
por: Hosseini, S., et al.
Publicado: (2016)

Establishing a Cutoff Serum Thyroglobulin Value for the Diagnosis and Management of Well-Differentiated Thyroid Cancer
por: Paudel, Jiwan
Publicado: (2023)

Optimization of Predictive Performance for the Therapeutic Response Using Iodine Scan-Corrected Serum Thyroglobulin in Patients with Differentiated Thyroid Carcinoma
por: Yoo, Su Woong, et al.
Publicado: (2020)

Prognostic Significance of Thyroglobulin Antibodies in Differentiated Thyroid Cancer
por: Reverter, Jordi L., et al.
Publicado: (2020)

Role of Preablative Stimulated Thyroglobulin in Prediction of Nodal and Distant Metastasis on Iodine Whole-Body Scan
por: Prabhu, Meghana, et al.
Publicado: (2018)

Role of Preablative-Stimulated Thyroglobulin in Prediction of Nodal and Distant Metastasis on Iodine Whole-body Scan
por: Bothra, Sapana, et al.
Publicado: (2018)

RECIST 1.1 and serum thyroglobulin measurements in the evaluation of responses to sorafenib in patients with radioactive iodine-refractory differentiated thyroid carcinoma
por: RUAN, MAOMEI, et al.
Publicado: (2013)

Thyroglobulin levels before radioactive iodine therapy and dynamic risk stratification after 1 year in patients with differentiated thyroid cancer
por: Bandeira, Leonardo, et al.
Publicado: (2017)

Correlation between Transient Ischemic Dilation Index and Endothelin-1 Level in Patients with Type 2 Diabetes Mellitus
por: Kartamihardja, Achmad Hussein Sundawa
Publicado: (2016)

Exploration of thyroglobulin as a biomarker of iodine status in iodine-sufficient and mildly iodine-deficient pregnant women
por: Dineva, Mariana, et al.
Publicado: (2023)

Predictive Role of Serum Thyroglobulin after Surgery and before Radioactive Iodine Therapy in Patients with Thyroid Carcinoma
por: Signore, Alberto, et al.
Publicado: (2023)

Application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma
por: Jiang, Nan, et al.
Publicado: (2023)

Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment
por: Klain, Michele, et al.
Publicado: (2019)

Thyroglobulin doubling time offers a better threshold than thyroglobulin level for selecting optimal candidates to undergo localizing [(18)F]FDG PET/CT in non-iodine avid differentiated thyroid carcinoma
por: Albano, Domenico, et al.
Publicado: (2020)

Pitfall in immunohistochemical staining for thyroglobulin in case of thyroid metastasis from lung carcinoma
por: Kanjanahattakij, Napatt, et al.
Publicado: (2015)

Reflection of Dietary Iodine in the 24 h Urinary Iodine Concentration, Serum Iodine and Thyroglobulin as Biomarkers of Iodine Status: A Pilot Study
por: Hlucny, Katelyn, et al.
Publicado: (2021)

High Thyroglobulin Antibody Levels Increase the Risk of Differentiated Thyroid Carcinoma
por: Qin, Jing, et al.
Publicado: (2015)

THYROGLOBULIN AS A TUMOR MARKER IN DIFFERENTIATED THYROID CANCER – CLINICAL CONSIDERATIONS
por: Prpić, Marin, et al.
Publicado: (2018)

The Prognostic Role of Postablative Non-Stimulated Thyroglobulin in Differentiated Thyroid Cancer
por: Szujo, Szabina, et al.
Publicado: (2021)

The Role of Thyroglobulin in Preoperative and Postoperative Evaluation of Patients With Differentiated Thyroid Cancer
por: Li, Sha, et al.
Publicado: (2022)

Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer
por: McFarland, Daniel C, et al.
Publicado: (2014)

Preoperative serum thyroglobulin is a risk factor of skip metastasis in papillary thyroid carcinoma
por: Huang, Ziyang, et al.
Publicado: (2020)

Pre-Therapeutic Measurements of Iodine Avidity in Papillary and Poorly Differentiated Thyroid Cancer Reveal Associations with Thyroglobulin Expression, Histological Variants and Ki-67 Index
por: Nilsson, Joachim N., et al.
Publicado: (2021)

Predictors of thyroglobulin in the lymph nodes recurrence of papillary thyroid carcinoma undergoing total thyroidectomy
por: Xing, Zhichao, et al.
Publicado: (2021)

Thyroid Receptor Antibody and the Development of Graves’ Orbitopathy: Clinical Experience of using Radioiodine Ablation in the Management of Graves’ Orbitopathy in post-iodine ablation hypothyroid patient
por: Christina, Edelyn, et al.
Publicado: (2023)

How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies
por: Spencer, Carole, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9iq4gag4j741nipr9j4dajmcgr